Skip to main content

Table 1 Characteristics of the 2954 included ductal carcinoma in situ (DCIS) lesions from the PALGA database between March 1, 2017 and March 1, 2018 (PRE feedback), and March 1, 2018 to March 1, 2019 (POST feedback)

From: Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports

 

Total (n = 2954)

PRE (n = 1493)

POST (n = 1461)

p-valueb

Histologic grade, n (%)

 Grade 1

383 (13.0%)

169 (11.3%)

214 (14.6%)

0.016

 Grade 2

1171 (39.6%)

590 (39.5%)

581 (39.8%)

 

 Grade 3

1400 (47.4%)

734 (49.2%)

666 (45.6%)

 

Age (y)a

59.8 (10.3)

59.8 (10.5)

59.8 (10.1)

0.922

Sex, n (%)

   

0.790

 Female

2943 (99.6%)

1487 (99.6%)

1456 (99.7%)

 

 Male

11 (0.4%)

6 (0.4%)

5 (0.3%)

 

Tumor size (cm)a

2.5 (2.3)

2.5 (2.3)

2.5 (2.3)

0.321

Type of surgery, n (%)

   

0.096

 Mastectomy

944 (32.0%)

456 (30.5%)

488 (33.4%)

 

 Breast conserving

2010 (68.0%)

1037 (69.5%)

973 (66.6%)

 
  1. a Mean (SD)
  2. b PRE vs POST categorical variables by Chi-square test, continuous variables by Mann Whitney U Test